Nothing Special   »   [go: up one dir, main page]

IL197982A0 - Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory - Google Patents

Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory

Info

Publication number
IL197982A0
IL197982A0 IL197982A IL19798209A IL197982A0 IL 197982 A0 IL197982 A0 IL 197982A0 IL 197982 A IL197982 A IL 197982A IL 19798209 A IL19798209 A IL 19798209A IL 197982 A0 IL197982 A0 IL 197982A0
Authority
IL
Israel
Prior art keywords
treatment
cardiovascular diseases
combined preparation
diseases based
chronotherapy
Prior art date
Application number
IL197982A
Original Assignee
Hanall Pharmacuetical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020070101492A external-priority patent/KR100888131B1/en
Application filed by Hanall Pharmacuetical Co Ltd filed Critical Hanall Pharmacuetical Co Ltd
Publication of IL197982A0 publication Critical patent/IL197982A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
IL197982A 2006-10-10 2009-04-05 Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory IL197982A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20060098438 2006-10-10
KR1020070101492A KR100888131B1 (en) 2006-10-10 2007-10-09 Combination preparation for Cardiovascular disease therapy by Chronotherapy theory.
PCT/KR2007/004929 WO2008044862A1 (en) 2006-10-10 2007-10-10 Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory

Publications (1)

Publication Number Publication Date
IL197982A0 true IL197982A0 (en) 2009-12-24

Family

ID=39533338

Family Applications (1)

Application Number Title Priority Date Filing Date
IL197982A IL197982A0 (en) 2006-10-10 2009-04-05 Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory

Country Status (2)

Country Link
IL (1) IL197982A0 (en)
ZA (1) ZA200903204B (en)

Also Published As

Publication number Publication date
ZA200903204B (en) 2010-07-28

Similar Documents

Publication Publication Date Title
IL186749A0 (en) Dihydrothienopyrimidines for the treatment of inflammatory diseases
EP2005168A4 (en) Methods and compositions for the diagnosis of diseases of the aorta
EP2118074A4 (en) Compounds for the prevention and treatment of cardiovascular diseases
IL202664A (en) Processes for the preparation of 3-dihalomethyl-1-methyl-1h- pyrazole-4-carbaldehyde and intermediates
PT2546253E (en) Substituted dihydropyrazolones for the treatment of cardiovascular and hematological diseases
IL193747A0 (en) New therapeutic combinations for the treatment of depression
HK1202558A1 (en) Compositions and methods for the therapy and diagnosis of influenza
PL2056842T3 (en) Modified-galactosyl ceramide for the treatment of cancerous diseases
GB0612096D0 (en) Functional imaging of the retina
ZA200901523B (en) Use of extracts for the treatment of viral disorders
GB0909297D0 (en) Composition for the treatment of skin conditions
GB0611240D0 (en) The treatment of increased sebum production
GB0611241D0 (en) The treatment of increased sebum production
GB0910201D0 (en) The preparation method of 2-deoxy-l-ribose
PL2044099T3 (en) Process for the preparation of s-fluoromethyl-6 ,9 -difluoro-11 -hydroxy-16 -methyl-17 -propionyloxy-3-oxo-androsta-1,4-diene-17 -carbothioate and intermediates
PL2307380T3 (en) N'-nitroxyalkylnicotinamides for the treatment of cardiovascular diseases
IL191887A0 (en) Method for the diagnosis and treatment of cardiovascular diseases
HK1185345A1 (en) Compounds for the prevention and treatment of cardiovascular diseases
IL197982A0 (en) Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theory
GB0602857D0 (en) The treatment of sialorrhoea
PL381142A1 (en) The manner of obtaining of glicydol
PL383170A1 (en) The manner of obtaining calcious preparation
GB0602858D0 (en) The treatment of sialorrhoea
GB0602855D0 (en) The Treatment Of Sialorrhoea
GB0609792D0 (en) The treatment of multiple sclerosis